Jefferies is delighted to have acted as Sole Financial Advisor to SoftwareOne, a leading global provider of software and cloud solutions, on its US$1.5bn public takeover of Crayon - the largest pan-European IT Services transaction since 2022, and one of just two US$1bn+ transactions in the broader European IT services market. This is Jefferies’ first public buy-side takeover transaction in Switzerland for a local corporate client, following the appointment of Vincent Thiebaud as Head of Switzerland Investment Banking in June 2024, a hire that underlines Jefferies’ commitment to further expanding its strong client offering in the DACH region.
Jefferies
Investment Banking
New York City, New York 434,491 followers
Jefferies, the global investment banking firm serving clients for more than 60 years.
About us
Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com.
- Website
-
http://Jefferies.com
External link for Jefferies
- Industry
- Investment Banking
- Company size
- 5,001-10,000 employees
- Headquarters
- New York City, New York
- Type
- Public Company
- Founded
- 1962
- Specialties
- Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services
Locations
Employees at Jefferies
Updates
-
On behalf of all of our Jefferies partners who operate in 47 offices in 21 countries, we’d like to thank our friends and clients for your support, trust, loyalty, and partnership this year. 2024 was a year of continued expansion and deepening of our capabilities throughout our firm, which we believe leaves us better positioned than ever to serve our clients. Hear more from Jefferies CEO Rich Handler and President Brian Friedman in their year-end letter below.
-
Raphael Bejarano, our Co-Head of Global Investment Banking and Capital Markets, spoke to Financial Times about the expectation for large deal activity to rebound in 2025, noting that higher interest rates and a “gap on value between buyer and seller expectations" affected deal volume in 2024. Read the full article here: http://spklr.io/6045L839
-
Jefferies is proud to have acted as Exclusive Financial Advisor to IWP, a leading provider of financial planning solutions across the UK with approximately £6.6bn of client assets, on its sale to Titan Wealth, a vertically integrated provider of wealth management solutions across financial planning, investment management, platform, and custody. The deal represents a significant milestone for IWP, as it crystallizes the work by its management team in restructuring the group, bringing all trading businesses into two legal entities and onto one operating platform.
-
We recently hosted the Fourth Annual Jefferies Global Real Estate Conference: Navigating the Complex World of Commercial Real Estate. The Jefferies Research & Investment Banking teams were excited to once again bring together REIT-focused companies and investors for another unique event. In addition to traditional one-on-one meetings, we held networking events, company Q&A breakout sessions, property tours, keynotes and panel discussions. See highlights from the event below.
-
Jefferies is delighted to have acted as Buyside M&A Advisor to Goldman Sachs Alternatives on its acquisition of a majority stake in Synthon, a leading platform specialized in developing, manufacturing, and out-licensing complex generic medicines, from funds advised by BC Partners. This high-profile transaction represents the 21st healthcare CDMO/pharma services M&A transaction Jefferies has advised on since 2020, further strengthening our leadership in the B2B pharma dossier segment in Europe, following the successful sale of Pharmathen for BC Partners to Partners Group in 2021. The deal adds to the more than 20 transactions Jefferies successfully completed in Benelux over the past 12 months, further cementing our leadership position in the pharma space and region.
-
Jefferies is excited to announce the launch of its 5th Annual U.S. Equity Research Mentorship Program. Jefferies Women’s Initiative Network (JWIN) invites current university students with diverse backgrounds and experiences who have an expected graduation date in 2027 to apply. This opportunity is to participate in a four-week program focused on mentorship, on-going training and professional development, and an exploration of a career in Equity Research. Successful applicants will be eligible to interview for a 2026 Equity Research summer internship at the end of the program. Applications are due by January 15, 2025. Finalists will be notified and provided additional details by January 31, 2025 and programming will begin February 10, 2025. Apply here: http://spklr.io/6044IfAI
-
Jefferies’ Sustainability & Transition Team recently sat down with Pierre Friedlingstein, Professor and Chair in Mathematical Modeling of the Climate System at the University of Exeter. Together, they explored what the latest data reveals about the trajectory of climate change—and whether net-zero efforts are up to the challenge. See the eight key takeaways from their discussion here: http://spklr.io/6040IFmq
-
Jefferies is happy to share that our UK REGAL Investment Banking team, led by Global Co-Head of Real Estate and EMEA Head of REGAL Rishi Bhuchar, was recently ranked #1 in the latest UK M&A Real Estate League Tables from Dealogic, earning 15% market share. Congratulations to the team on a strong performance!
-
Jefferies is proud to have advised EQT & GIC on the acquisition of a majority stake in Calisen from funds managed by Global Infrastructure Partners (GIP), as part of BlackRock, the Infrastructure business of Goldman Sachs Alternatives and Mubadala Investment Company. Calisen is a leading independent provider of smart meters and energy transition infrastructure in the UK. Congratulations to all on this successful transaction!
Similar pages
Browse jobs
Stock
JEF
NYSE
20 minutes delay
$76.19
0.93 (1.236%)
- Open
- 74.61
- Low
- 74.29
- High
- 77.02
Data from Refinitiv
See more info on